ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences third quarter 2023 earnings call.
Reshape Lifesciences Inc. (RSLS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.52 | 17,702 | Officer | 23,490 | 2023-06-30 | Filing | |
| $0.95 | 1,228 | Officer | 365,627 | 2022-05-31 | Filing | |
| $0.94 | 6,539 | Officer | 364,399 | 2022-05-31 | Filing | |
| $0.93 | 60 | Officer | 357,860 | 2022-05-31 | Filing | |
| $0.92 | 7,995 | Officer | 357,800 | 2022-05-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.27 | 131 | Officer | 22,949 | 2023-10-25 | Filing | |
| $0.93 | 39 | Officer | 23,080 | 2023-10-11 | Filing | |
| $0.89 | 118 | Officer | 23,119 | 2023-09-01 | Filing | |
| $1.42 | 39 | Officer | 23,237 | 2023-08-24 | Filing | |
| $1.43 | 108 | Officer | 23,276 | 2023-08-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences second quarter 2023 earnings call.
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences first quarter 2023 earnings call.
Billionaire Hedge Funds
